Market Research Reports Global Precision Medicine Market

Rapid Growth of Global Precision Medicine Market
2019|Forecast to 2023
The demand for Precision Medicine Market
2019 is anticipated to be high for the next
few years. By considering this demand we
provide latest Precision Medicine Market
Report which gives complete industry
analysis, market outlook, size, growth and
forecast till 2023. This report will assist in
analyzing the current and future business
trends, sales and revenue forecasts.
Global Precision Medicine Market Synopsis:
The global precision medicine market has benefitted greatly from advancements in the life science
industry. Although in its nascent stage, targeted therapies hold high chances of becoming a massive
success in the coming years because of the potential to treat and cure chronic illnesses. The market is
thus expected to expand at a compound annual growth rate (CAGR) of 11.60% between 2018 and 2023,
generating USD 88.25 Bn in revenue by 2023.
The Global “Precision Medicine Market” research 2019 highlights the major details and provides in-
depth analysis of the market along with the future growth, prospects and Industry demands analysis
explores with the help of complete report with 90 Pages, figures, graphs and table of contents to
analyze the situations of global Precision Medicine Market and Assessment to 2023.
Get Exclusive Sample Study Papers of “Global Precision Medicine Market” @
https://www.businessindustryreports.com/sample-request/174384 .
Diagnostic companies held the largest share of the market in 2018, contributing to approximately 39%
of the global revenues. They are expected to continue dominating the market during the assessment
period, owing to the dominant role that precision medicine plays in diagnosing potential diseases.
Pharmaceutical companies are next in line to dominate the market, accounting for a market share of
29% in 2018 due to the increasing efforts put in research and development for developing drugs.
Therapeutic segment insights
Among the therapeutic areas of precision medicine, cancer held the largest share of the market by
generating almost 33% of the global market revenue in 2018. Development of targeted novel therapies